LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci
- 1 January 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (1) , 141-143
- https://doi.org/10.1128/aac.32.1.141
Abstract
Rabbits with group G streptococcal aortic endocarditis received no therapy (controls); repeated doses of procaine penicillin G, 300 mg/kg (body weight) per day, administered intramuscularly; or LY146032, a new peptolide antibiotic, 20 mg/kg per day, administered intravenously. Penicillin G and LY146032 reduced mean intravegetation group G streptococcal densities significantly below those observed in controls at both day 3 and day 6 of therapy. Penicillin G effected a more rapid clearance of intravegetation streptococci than LY146032 by day 3, but not by day 6, of therapy.This publication has 15 references indexed in Scilit:
- In vitro activity of LY146032 against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1986
- Group G streptococcal endocarditis and bacteremiaThe American Journal of Medicine, 1986
- Infections Due to Lancefield Group G StreptococciMedicine, 1985
- Serious infections due to group G streptoccocciThe American Journal of Medicine, 1983
- Group G Streptococcal Bacteremia: Clinical Study and Review of the LiteratureClinical Infectious Diseases, 1983
- Therapy of Experimental Pseudomonas Endocarditis with High-Dose Amikacin and TicarcillinChemotherapy, 1983
- Septic Arthritis due to Group G StreptococcusJAMA, 1982
- Comparison of a Micromethod for Performance of the Serum Bactericidal Test with the Standard Tube Dilution MethodAntimicrobial Agents and Chemotherapy, 1979
- Experimental Endocarditis Due to Pseudomonas aeruginosa. I. Description of a ModelThe Journal of Infectious Diseases, 1976
- Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureusThe Journal of Infectious Diseases, 1975